Safety and efficacy of levodopa-carbidopa intestinal gel: results from an open-label extension study in Japanese, Korean and Taiwanese patients with advanced Parkinson’s disease-Reference-Cited by-同舟云学术

Safety and efficacy of levodopa-carbidopa intestinal gel: results from an open-label extension study in Japanese, Korean and Taiwanese patients with advanced Parkinson’s disease

Published:2018-01 Issue: Volume:11 Page:175628641875931
ISSN:1756-2864
Container-title:Therapeutic Advances in Neurological Disorders
language:en
Short-container-title:Ther Adv Neurol Disord

Author:

Murata Miho¹,Mihara Masahito²,Hasegawa Kazuko³,Jeon Beomseok⁴,Tsai Chon-Haw⁵,Nishikawa Noriko⁶,Oeda Tomoko⁷,Yokoyama Masayuki⁸,Robieson Weining Z.⁹,Chatamra Krai⁹,Facheris Maurizio F.⁹,Benesh Janet⁹

Affiliation:

1. National Center of Neurology and Psychiatry, 4-1-1 Ogawa-Higashi, Kodaira 187-8551, Tokyo, Japan

2. Osaka University Graduate School of Medicine, Suita, Japan

3. National Hospital Organization Sagamihara National Hospital, Sagamihara, Japan

4. Seoul National University Hospital, Seoul, Republic of Korea

5. Department of Neurology, China Medical University Hospital Medical College, China Medical University, Taichung, Taiwan

6. Ehime University Hospital, Matsuyama, Japan

7. National Hospital Organization Utano Hospital, Kyoto, Japan

8. AbbVie Inc., Tokyo, Japan

9. AbbVie Inc., North Chicago, Illinois, USA

Publisher

SAGE Publications